Exon 21 was replaced with a modified exon in which nucleotide substitutions (GAT to GCT) results in the amino acid substitution of alanine for aspartic acid at position 813 (D813A) and an FRT-flanked neo cassette. Flp-mediated recombination removed the neo cassette.